Life-threatening motor neurotoxicity in association with bortezomib.
Haematologica
; 91(7): 1001, 2006 Jul.
Article
in En
| MEDLINE
| ID: mdl-16757419
ABSTRACT
Bortezomib has been licensed to be used in relapsed and refractory multiple myeloma. It is a promising agent for this incurable condition but our effort is to caution hematologists about the life-threatening neurotoxicity (grade 4) which was seen in two of six patients treated with this agent although the complication cannot definitely be attributed to bortezomib.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrazines
/
Boronic Acids
/
Neurotoxicity Syndromes
Type of study:
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Haematologica
Year:
2006
Type:
Article